Need a specific person's email?
Browse NeoPhore Ltd's employee directory (about 16 employees) and reveal verified emails free.
NeoPhore Ltd's most common email format is First.Last@neophore.com (ex. John.Doe@neophore.com), used for 89% of neophore.com addresses. NeoPhore Ltd uses 2 email patterns.
| Format | Example | Share of neophore.com |
|---|---|---|
| First.Last@neophore.comMost common | John.Doe@neophore.com | |
| First@neophore.com | John@neophore.com |
Browse NeoPhore Ltd's employee directory (about 16 employees) and reveal verified emails free.
Biotechnology ResearchEngland, United Kingdom11-50 Employees
NeoPhore Ltd is a London-based biotechnology research company focused on cancer immunotherapy. The company aims to broaden access to disease-transforming immunotherapy by transiently inhibiting DNA Mismatch Repair to replicate the strong responses seen in patients with MMR-deficient tumors. Its work seeks to extend the proven benefits of immunotherapy to more cancer patients, operating within the oncology research space with a compact team. Its intended customers are cancer patients seeking new treatment options and the clinical researchers and clinicians advancing immuno-oncology. In April 2026, NeoPhore published findings in AACR Cancer Discovery on PMS2 inhibition inducing MMR deficiency and enhancing responses to immune checkpoint blockade, a development highlighted alongside a keynote by co-founder Prof. Alberto Bardelli at the 2026 AACR Annual Meeting.
Most common format
First.Last@neophore.com
Example: John.Doe@neophore.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.